The study found the 30mg/kg nipocalimab group had a statistically significant durable haemoglobin response by week 24.

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

A one-year randomized trial found that daily prune supplementation did not improve total or lumbar spine bone mineral density ...

Women aged 40 and older with node-positive early breast cancer, a group traditionally routed straight to chemotherapy, may ...

The results showed obefazimod met the FDA primary endpoint of placebo-adjusted clinical remission at week 44.

LTI-03 in idiopathic pulmonary fibrosis (IPF)First patient randomized in the United KingdomClinical trial sites now actively ...

PREDICT-1 is the first genotype-based registrational trial in dry eye disease (DED), with the potential of delivering a first-in-class precision medicine treatment in DEDThis FDA-aligned trial targets ...

The 2026 ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Michael Ong discussing TRIPLE-SWITCH (SWOG/CCTG-PR26), a randomized phase III clinical ...

Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...

Introduction Critical care patients face varying degrees of physical and psychological stress; in recent decades, the increasing focus on technologies and clinical processes has led to dehumanisation.